Skip to main navigation Skip to search Skip to main content

Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study

  • Claudio Bonifati
  • , Giuseppe Argenziano
  • , Serena Lembo
  • , Antonio Giovanni Richetta
  • , Marco Romanelli
  • , Francesca Satolli
  • , Monica Corazza
  • , Laura Atzori
  • , Claudia Lasagni
  • , Concetta Potenza
  • , Paola Savoia
  • , Federico Bardazzi
  • , Vito Giuseppe Di Lernia
  • , Marco Galluzzo
  • , Matteo Megna
  • , Claudia Giofrè
  • , Leonardo Zichichi
  • , Claudio Guarneri
  • , Sabatino Pallotta
  • , Maria Concetta Fargnoli
    • Francesco Loconsole, Annamaria Offidani, Martina Burlando, Stefano Piaserico, Ketty Peris, Manuela Papini, Carlo Giovanni Carrera, Francesca Prignano, Maria Rita Bongiorno, Paolo Dapavo, Luca Stingeni, Massimo Donini, Giuseppe Micali, Franco Rongioletti, Giuseppe Stinco, Federico Saibene, Talia Gramiccia, Antonio Costanzo

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry